Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Carcinoma
>>
AKT inhib
>>
Phase 2
Welcome,
Profile
Billing
Logout
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
3
6
9
12
15
18
21
24
27
30
MK-2206
/ Merck (MSD)
perifosine
(D21266) / AEterna Zentaris
7-Hydroxystaurosporine
(UCN-01) / National Cancer Institute
Viracept
(nelfinavir) / ViiV Healthcare, Roche
sonolisib
(PX 866) / Pfizer
Kinenza
(enzastaurin) / Denovo, Aytu BioPharma
quinacrine
(CBL0102) / Incuron